UFF
TECH icon

USA Financial Formulas’s Bio-Techne TECH Stock Holding History

USA Financial Formulas’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,740
Closed -$332K – 486
2021
Q3 		$332K Buy
+2,740
New +$333K 0.3% 103
2021
Q1 		– Sell
-4,836
Closed -$384K – 428
2020
Q4 		$384K Buy
+4,836
New +$350K 0.3% 85
2019
Q4 		– Sell
-8
Closed – – 307
2019
Q3 		$0 Buy
+8
New +$401 ﹤0.01% 262
2019
Q1 		– Sell
-19,124
Closed -$976K – 321
2018
Q4 		$976K Buy
+19,124
New +$799K 0.24% 70

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

USA Financial Formulas's TECH Position: Q4 2021 in Review

USA Financial Formulas sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 2,740 shares — an estimated $332K sold.

USA Financial Formulas first reported a position in TECH in Q4 2018 and held it in 4 quarters. The position peaked at $976K in Q4 2018. 575 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

  • USA Financial Formulas reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
  • USA Financial Formulas sold 2,740 Bio-Techne shares in Q4 2021, an estimated $332K.
  • USA Financial Formulas first reported a position in Bio-Techne in Q4 2018 and held it in 4 quarters.
  • USA Financial Formulas's Bio-Techne position peaked at $976K in Q4 2018.
  • 575 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on USA Financial Formulas's 13F filing for Q4 2021, filed 10 Feb 2022.